Flowonix

15 articles about Flowonix

• Flowonix Medical, Inc. and SWK Holdings Corporation Announce Closing of $33 Million Financing

  1/4/2021

  Flowonix Medical, Inc., a medical device company focused on providing advanced, implantable drug delivery solutions and SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small and mid-sized commercial-stage companies, announced today that they have closed an approximate $33 mi

• Flowonix And Cerebral Therapeutics Announce Fifth Implant Of First-Of-A-Kind Implantable Drug Therapy To Treat Patients With Refractory Epilepsy

  10/3/2017

• Flowonix Release: First Implantable Pump Delivers Drugs Directly Into Brains Of Epileptic Patients

  3/17/2017

• Flowonix And Cerebral Therapeutics Announce World-First Clinical Trial Delivering Medication Directly Into The Brain For Patients With Refractory Epilepsy

  3/15/2017

• Flowonix Completes $15.5 Million Financing

  6/2/2016

• Flowonix Taps a New CEO

  5/19/2016

• Flowonix And Cerebral Therapeutics, LLC Announce Exclusive Agreement For Drug Delivery To Brain

  10/21/2015

• Flowonix Medical, Inc. Announces First Use of Its Patient Therapy Controller (PTC)

  8/31/2015

• Flowonix Announces FDA Approval Of New Product

  8/7/2015

• Flowonix And Alliance Spine And Pain Centers Announce First Prometra II Implant In Georgia

  6/29/2015

• Flowonix Announces First Implants of Prometra II

  5/6/2015

• Proven Process Client Flowonix Achieves FDA PMA(S) Approval Of Prometra II Infusion Device

  4/2/2015

• Flowonix Announces FDA PMA(S) Approval Of Prometra II

  1/19/2015

• Flowonix Banks $40 Million Financing

  11/11/2014

• Flowonix Submits PMA Supplements for Prometra® Implantable Pump System

  9/15/2014